TOKYO, Jun 10 (Pulse News Wire) – Kringle Pharma,inc. (4884.T) has set June 30, June 10, 2026 as the record date for its upcoming extraordinary general meeting scheduled for August 2026.
Shareholders recorded in the final shareholder registry on that day will be eligible to vote at the meeting. The agenda for the meeting includes proposals related to the reduction of capital stock and surplus reserves.
Further details will be disclosed once finalized during future board meetings. Announcement methods for the meeting will include electronic notice posted on the company’s official website.
Interested shareholders should monitor the site for updates.
🟡 Confidence: Standard AI-translated content.